Literature DB >> 18321438

Surgical management of gastric cancer: review and consideration for total care of the gastric cancer patient.

Samielle Brancato1, Thomas J Miner.   

Abstract

Surgical therapy remains the most effective modality in the treatment of gastric cancer. Staging laparoscopy with laparoscopic ultrasound may increase the accuracy of staging and prevent patients with unresectable gastric cancer from undergoing unnecessary operations. Resection of proximal and distal gastric cancer is best accomplished with an appropriate gastrectomy that ensures adequate resection margins. A D2 lymphadenectomy can be performed safely and facilitates the resection of the minimum 15 lymph nodes required for adequate staging. Adjacent organ resection should be used only in highly selected patients with R0 resection as the goal. Palliative operations offer improved quality of life and symptom relief in patients with metastatic disease. Appreciation of postoperative quality of life after gastric resection facilitates appropriate and effective preoperative counseling. Surgical outcomes may be influenced by hospital volume and rate of adequate lymph node assessment.

Entities:  

Year:  2008        PMID: 18321438     DOI: 10.1007/s11938-008-0023-9

Source DB:  PubMed          Journal:  Curr Treat Options Gastroenterol        ISSN: 1092-8472


  47 in total

1.  Hand-assisted laparoscopic function- preserving and radical gastrectomies for advanced-stage proximal gastric cancer.

Authors:  Ichiro Uyama; Atsushi Sugioka; Yoichi Sakurai; Yoshiyuki Komori; Tsunekazu Hanai; Hideo Matsui; Junko Fujita; Yasuko Nakamura; Masahiro Ochiai; Akitake Hasumi
Journal:  J Am Coll Surg       Date:  2004-09       Impact factor: 6.113

Review 2.  Laparoscopic surgical resection for early gastric cancer.

Authors:  Seigo Kitano; Kazuhiro Yasuda; Norio Shiraishi
Journal:  Eur J Gastroenterol Hepatol       Date:  2006-08       Impact factor: 2.566

3.  Clinical outcomes with laparoscopic stage M1, unresected gastric adenocarcinoma.

Authors:  Abeezar I Sarela; Thomas J Miner; Martin S Karpeh; Daniel G Coit; David P Jaques; Murray F Brennan
Journal:  Ann Surg       Date:  2006-02       Impact factor: 12.969

4.  Is there a benefit of pancreaticosplenectomy with gastrectomy for advanced gastric cancer?

Authors:  Y Kasakura; M Fujii; F Mochizuki; M Kochi; T Kaiga
Journal:  Am J Surg       Date:  2000-03       Impact factor: 2.565

5.  Laparoscopic gastrectomy with regional lymph node dissection for upper gastric cancer.

Authors:  S Tanimura; M Higashino; Y Fukunaga; S Kishida; A Ogata; Y Fujiwara; H Osugi
Journal:  Br J Surg       Date:  2007-02       Impact factor: 6.939

6.  Extended lymph-node dissection for gastric cancer.

Authors:  J J Bonenkamp; J Hermans; M Sasako; C J van de Velde; K Welvaart; I Songun; S Meyer; J T Plukker; P Van Elk; H Obertop; D J Gouma; J J van Lanschot; C W Taat; P W de Graaf; M F von Meyenfeldt; H Tilanus
Journal:  N Engl J Med       Date:  1999-03-25       Impact factor: 91.245

7.  T4 gastric carcinoma: the benefit of non-curative resection.

Authors:  Dong Y Kim; Jae K Joo; Kyeung W Seo; Young K Park; Seong Y Ryu; Hyeong R Kim; Young J Kim; Shin K Kim
Journal:  ANZ J Surg       Date:  2006-06       Impact factor: 1.872

8.  Palliative gastrectomy in advanced gastric cancer: is it worthwhile?

Authors:  Inian Samarasam; B Sudhakar Chandran; V Sitaram; Benjamin Perakath; Aravindan Nair; George Mathew
Journal:  ANZ J Surg       Date:  2006 Jan-Feb       Impact factor: 1.872

9.  Prospective comparison of D1 vs modified D2 gastrectomy for carcinoma.

Authors:  P Edwards; G R J C Blackshaw; W G Lewis; J D Barry; M C Allison; D R B Jones
Journal:  Br J Cancer       Date:  2004-05-17       Impact factor: 7.640

10.  Survival results of a multicentre phase II study to evaluate D2 gastrectomy for gastric cancer.

Authors:  M Degiuli; M Sasako; A Ponti; F Calvo
Journal:  Br J Cancer       Date:  2004-05-04       Impact factor: 7.640

View more
  2 in total

1.  Research of shRNAmir inhibitory effects towards focal adhesion kinase expression in the treatment of gastric cancer.

Authors:  Guo-Qiang Su; Fu-Xing Zhang; He-Hui Mao; Xian-Wei Liu; Yong-Sheng Zheng; Si-Yu Zhang; Jing-Jun Su
Journal:  Oncol Lett       Date:  2014-11-21       Impact factor: 2.967

Review 2.  Gastric Adenocarcinoma: A Multimodal Approach.

Authors:  Humair S Quadri; Brandon G Smaglo; Shannon J Morales; Anna Chloe Phillips; Aimee D Martin; Walid M Chalhoub; Nadim G Haddad; Keith R Unger; Angela D Levy; Waddah B Al-Refaie
Journal:  Front Surg       Date:  2017-08-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.